DZNep inhibits H3K27me3 deposition and delays retinal degeneration in the rd1 mice | Cell Death & Disease
Proposed mechanism by which DZNep epigenetically reactivates... | Download Scientific Diagram
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy
A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep
3-Deazaneplanocin A - an overview | ScienceDirect Topics
![DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/11374/1/fig-5-full.png "DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]")
DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]
3-Deazaneplanocin A (DZNep), an Inhibitor of S-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation - ScienceDirect
Histone Methylation Inhibitor DZNep Ameliorated the Renal Ischemia-Reperfusion Injury via Inhibiting TIM-1 Mediated T Cell Activation | Medicine - Frontiers
PRC2 subunit composition and modes of inhibition. Three types of... | Download Scientific Diagram
DZNep and UNC0642 enhance in vitro developmental competence of cloned pig embryos in: Reproduction Volume 157 Issue 4 (2018)
Inhibition of juvenile hormone synthesis in mosquitoes by the methylation inhibitor 3-deazaneplanocin A (DZNep) - ScienceDirect
Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells
DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. - Abstract - Europe PMC
3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells
Frontiers | Histone Methylation Inhibitor DZNep Ameliorated the Renal Ischemia-Reperfusion Injury via Inhibiting TIM-1 Mediated T Cell Activation | Medicine
Cancers | Free Full-Text | Co-Treatment with the Epigenetic Drug, 3-Deazaneplanocin A (DZNep) and Cisplatin after DZNep Priming Enhances the Response to Platinum-Based Therapy in Chondrosarcomas | HTML
3-Deazaneplanocin,DZNep | CAS:102052-95-9 | Cell-permeable histone methyltransferase inhibitor | High Purity | Manufacturer BioCrick
The Effect of EZH2 Inhibition through DZNep on Epithelial–Mesenchymal Transition Mechanism | Cellular Reprogramming
Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis
Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model | BMC Cancer | Full Text
3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells
3-Deazaneplanocin A hydrochloride (DZNep hydrochloride) | EZH2 Inhibitor | MedChemExpress
![DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/11374/1/fig-2-full.png "DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]")